|
|
| (7 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | *'''[[Diagnosis (Laboratory other parameters)]]''' | | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | *'''[[Dx PCR]]''' | | *'''[[Dx PCR]]''' |
| | *'''[[Dx Antigen]]''' | | *'''[[Dx Antigen]]''' |
| Zeile 10: |
Zeile 12: |
| | | | |
| | ---- | | ---- |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| |
| − | {{tp|p=32378843|t=2020. Akutt lungesviktsyndrom hos covid-19-pasient med negative nasofarynksprover |pdf=|usr=}}
| |
| − | {{tp|p=32403009|t=2020. Five-minute point-of-care testing for SARS-CoV-2: Not there yet |pdf=|usr=}}
| |
| − | {{tp|p=32372836|t=2020. The problems with so-called immunity tests |pdf=|usr=}}
| |
| − | {{tp|p=32475012|t=2020. Testing for SARS-CoV-2: the day the world turned its attention to the clinical laboratory.|pdf=|usr=007}}
| |
| − | {{tp|p=32320539|t=2020. La Asociacion Catalana de Salud Laboral (@SCSL) ante el gran reto de la COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32469511|t=2020. Virus Detection: What Were We Doing before COVID-19 Changed the World?|pdf=|usr=008}}
| |
| − | {{tp|p=32395391|t=2020. Development of a rapid test kit for SARS-CoV-2: an example of product design.|pdf=|usr=008}}
| |
| − | {{tp|p=32490854|t=2020. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.|pdf=|usr=008}}
| |
| − | {{tp|p=32452225|t=2020. Nasopharyngeal swab or clinical-radiological evidence: the dark side of the moon for cancer patients in the COVID-19 era.|pdf=|usr=008}}
| |
| − | {{tp|p=32504943|t=2020. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing.|pdf=|usr=008}}
| |
| − | {{tp|p=32473233|t=2020. Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive.|pdf=|usr=008}}
| |
| − | {{tp|p=32496708|t=2020. COVID-19 : quelle place, aujourd'hui, pour les tests serologiques ?|pdf=|usr=008}}
| |
| − |
| |
| − | ===009===
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32434518|t=2020. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.|pdf=|usr=009}}
| |
| − | {{tp|p=32383793|t=2020. Lung Ultrasound and the COVID-19 "Pattern": Not All That Glitters Today Is Gold Tomorrow.|pdf=|usr=009}}
| |
| − | {{tp|p=32383781|t=2020. On Lung Ultrasound Patterns Specificity in the Management of COVID-19 Patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32395910|t=2020. Contrast-Enhanced Ultrasound in Patients With COVID-19: Pneumonia, Acute Respiratory Distress Syndrome, or Something Else?|pdf=|usr=009}}
| |
| − | {{tp|p=32227492|t=2020. Proposal for International Standardization of the Use of Lung Ultrasound for Patients With COVID-19: A Simple, Quantitative, Reproducible Method.|pdf=|usr=009}}
| |
| − | {{tp|p=32513550|t=2020. Diagnosis of Asymptomatic COVID-19 Infection in a Patient Referred for CT Lung Biopsy.|pdf=|usr=009}}
| |
| − | {{tp|p=32445875|t=2020. Ion torrent-based nasopharyngeal swab metatranscriptomics in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32421144|t=2020. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.|pdf=|usr=009}}
| |
| − | {{tp|p=32310815|t=2020. Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples.|pdf=|usr=009}}
| |
| − | {{tp|p=32533391|t=2020. Study on the dynamic change law and correlation between CT imaging manifestations and cellular immunity of 2019 novel coronavirus disease.|pdf=|usr=009}}
| |
| − | {{tp|p=32529815|t=2020. Assessment of the Severity of Coronavirus Disease: Quantitative Computed Tomography Parameters versus Semiquantitative Visual Score.|pdf=|usr=009}}
| |
| − | {{tp|p=32410416|t=2020. Rapidly Progressive COVID-19 Pneumonia: What Radiologists Should Do.|pdf=|usr=009}}
| |
| − | {{tp|p=32410413|t=2020. Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32410412|t=2020. Association between Initial Chest CT or Clinical Features and Clinical Course in Patients with Coronavirus Disease 2019 Pneumonia.|pdf=|usr=009}}
| |
| − | {{tp|p=32524793|t=2020. COVID-19 Carrier or Pneumonia: Positive Real-Time Reverse-Transcriptase Polymerase Chain Reaction but Negative or Positive Chest CT Results.|pdf=|usr=009}}
| |
| − | {{tp|p=32524792|t=2020. Early CT Findings of Coronavirus Disease 2019 (COVID-19) in Asymptomatic Children: A Single-Center Experience.|pdf=|usr=009}}
| |
| − | {{tp|p=32524786|t=2020. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32373786|t=2020. Cautions about radiologic diagnosis of COVID-19 infection driven by artificial intelligence.|pdf=|usr=009}}
| |
| − | {{tp|p=32473662|t=2020. Implication of SARS-CoV-2 evolution in the sensitivity of RT-qPCR diagnostic assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32445709|t=2020. RT-PCR for SARS-CoV-2: quantitative versus qualitative.|pdf=|usr=009}}
| |
| − | {{tp|p=32422197|t=2020. Who is most likely to be infected with SARS-CoV-2?|pdf=|usr=009}}
| |
| − | {{tp|p=32311327|t=2020. Rural areas at risk during COVID-19 pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32445713|t=2020. A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation.|pdf=|usr=009}}
| |
| − | {{tp|p=32479792|t=2020. Testing for COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32437649|t=2020. Challenges in the interpretation and application of typical imaging features of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32526509|t=2020. Could MEFV mutation carriage status have a protective role for COVID-19 pandemic?|pdf=|usr=009}}
| |
| − | {{tp|p=32425648|t=2020. A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients.|pdf=|usr=009}}
| |
| − | {{tp|p=32425334|t=2020. Sequence mismatch in PCR probes may mask the COVID-19 detection in Nepal.|pdf=|usr=009}}
| |
| − | {{tp|p=32529418|t=2020. The Potential Role of Smartphone-Based Microfluidic Systems for Rapid Detection of COVID-19 Using Saliva Specimen.|pdf=|usr=009}}
| |
| − | {{tp|p=32379456|t=2020. Emerging Biomolecular Testing to Assess the Risk of Mortality from COVID-19 Infection.|pdf=|usr=009}}
| |
| − | {{tp|p=32376571|t=2020. [Effect of heat inactivation of blood samples on the efficacy of three detection methods of SARS-CoV-2 antibodies].|pdf=|usr=009}}
| |
| − | {{tp|p=32518804|t=2020. Correlation Between Chest CT Findings and Clinical Features of 211 COVID-19 Suspected Patients in Wuhan, China.|pdf=|usr=009}}
| |
| − | {{tp|p=32410825|t=2020. How to increase the SARS-CoV-2 detection rate through the nasopharyngeal swab?|pdf=|usr=009}}
| |
| − | {{tp|p=32528619|t=2020. Leveraging polymerase chain reaction technique (GeneXpert) to upscaling testing capacity for SARS-CoV-2 (COVID-19) in Nigeria: a game changer.|pdf=|usr=009}}
| |
| − | {{tp|p=32450346|t=2020. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.|pdf=|usr=009}}
| |
| − | {{tp|p=32530929|t=2020. Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification.|pdf=|usr=009}}
| |
| − | {{tp|p=32504802|t=2020. Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays.|pdf=|usr=009}}
| |
| − | {{tp|p=32411942|t=2020. Covid-19: round and oval areas of ground-glass opacity.|pdf=|usr=009}}
| |
| − | {{tp|p=32407516|t=2020. Response to letter to the editor: "Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction".|pdf=|usr=009}}
| |
| − | {{tp|p=32407487|t=2020. Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction.|pdf=|usr=009}}
| |
| − | {{tp|p=32489938|t=2020. Radiological follow-up of twelve COVID-19 patients with initially normal chest CT.|pdf=|usr=009}}
| |
| − | {{tp|p=32489937|t=2020. Should computed tomography (CT) be used as a screening or follow-up tool for asymptomatic patients with SARS-CoV-2 infection?|pdf=|usr=009}}
| |
| − | {{tp|p=32489936|t=2020. Computed tomography (CT) intestinal alterations of Coronavirus Disease 2019 (COVID-19) from the imaging perspective: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489931|t=2020. Early minimal lesions of COVID-19 pneumonia with interstitial lung abnormality: a case description.|pdf=|usr=009}}
| |
| − | {{tp|p=32489929|t=2020. A systematic review of chest imaging findings in COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32410816|t=2020. A case series of chest imaging manifestation of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32423842|t=2020. False negative chest X-Rays in patients affected by COVID-19 pneumonia and corresponding chest CT findings.|pdf=|usr=009}}
| |
| − | {{tp|p=32406420|t=2020. High-resolution CT features of the COVID-19 infection in Nanchong City: Initial and follow-up changes among different clinical types.|pdf=|usr=009}}
| |
| − | {{tp|p=32399481|t=2020. Computed tomography findings in a case of coronavirus disease 2019.|pdf=|usr=009}}
| |
| − | {{tp|p=32519256|t=2020. Chest X-ray in new Coronavirus Disease 2019 (COVID-19) infection: findings and correlation with clinical outcome.|pdf=|usr=009}}
| |
| − | {{tp|p=32500510|t=2020. Radiological management of COVID-19: structure your diagnostic path to guarantee a safe path.|pdf=|usr=009}}
| |
| − | {{tp|p=32500509|t=2020. Chest CT features of coronavirus disease 2019 (COVID-19) pneumonia: key points for radiologists.|pdf=|usr=009}}
| |
| − | {{tp|p=32515676|t=2020. Cardiac MRI of Children with Multisystem Inflammatory Syndrome (MIS-C) Associated with COVID-19: Case Series.|pdf=|usr=009}}
| |
| − | {{tp|p=32216718|t=2020. Chest Radiograph Findings in Asymptomatic and Minimally Symptomatic Quarantined Patients in Codogno, Italy during COVID-19 Pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32447034|t=2020. The simulation-CT: Radiotherapy's useful tool in the race against COVID-19 pandemic. A serendipity approach.|pdf=|usr=009}}
| |
| − | {{tp|p=32469732|t=2020. Chest X-ray features of SARS-CoV-2 in the emergency department: a multicenter experience from northern Italian hospitals.|pdf=|usr=009}}
| |
| − | {{tp|p=32527255|t=2020. Predictors of fatality including radiographic findings in adults with COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32406576|t=2020. Serum amyloid A is a predictor for prognosis of COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32520136|t=2020. COVID-19: the virus in the control of culture?|pdf=|usr=009}}
| |
| − | {{tp|p=32520135|t=2020. A brief history of medical uniforms: from ancient history to the COVID-19 time.|pdf=|usr=009}}
| |
| − | {{tp|p=32419706|t=2020. Guia basica ecografia pulmonar y COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32426303|t=2020. DIAGNOSTICO DE NEUMONIA COVID 19 EN PACIENTES ASINTOMATICOS TRAS LA REALIZACION DE UN PET-TC ONCOLOGICO.|pdf=|usr=009}}
| |
| − | {{tp|p=32449374|t=2020. Laboratory findings of COVID-19: a systematic review and meta-analysis.|pdf=|usr=009}}
| |
| − | {{tp|p=32347067|t=2020. [Optimization of a fluorescent qPCR detection for RNA of SARS-CoV-2].|pdf=|usr=009}}
| |
| − | {{tp|p=32395897|t=2020. Recent progress on the diagnosis of 2019 Novel Coronavirus.|pdf=|usr=009}}
| |
| − | {{tp|p=32534208|t=2020. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.|pdf=|usr=009}}
| |
| − | {{tp|p=32419875|t=2020. Antikorpertests bei COVID-19 - Was uns die Ergebnisse sagen.|pdf=|usr=009}}
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32589164|t=2020. Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019.|pdf=|usr=010}}
| |
| − | {{tp|p=32562554|t=2020. The role of peripheral blood eosinophil counts in COVID-19 patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32565235|t=2020. Lung ultrasound as an extension of medical examination for COVID-19 pneumonia: much more than an imaging technique.|pdf=|usr=010}}
| |
| − | {{tp|p=32564467|t=2020. Anti-cardiolipin IgG autoantibodies are an independent risk factor of COVID-19 severity.|pdf=|usr=010}}
| |
| − | {{tp|p=32573254|t=2020. Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience.|pdf=|usr=010}}
| |
| − | {{tp|p=32576224|t=2020. CT findings of patients infected with SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32539692|t=2020. Imaging features of the initial chest thin-section CT scans from 110 patients after admission with suspected or confirmed diagnosis of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32592709|t=2020. Chest CT imaging signature of COVID-19 infection: in pursuit of the scientific evidence.|pdf=|usr=010}}
| |
| − | {{tp|p=32569635|t=2020. Differences of SARS-CoV-2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens among Adult Inpatients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32543160|t=2020. Thoracic Computed Tomography Features of Coronavirus Disease 2019 Patients with Emphysema.|pdf=|usr=010}}
| |
| − | {{tp|p=32592724|t=2020. Room-temperature-storable PCR Mixes for SARS-CoV-2 Detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32569631|t=2020. Impact of Heat-Inactivation on the detection of SARS-CoV-2 IgM and IgG Antibody by ELISA.|pdf=|usr=010}}
| |
| − | {{tp|p=32585417|t=2020. Bringing radiology to patient's home using mobile equipment: A weapon to fight COVID-19 pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32585353|t=2020. Large-scale implementation of pooled RNA extraction and RT-PCR for SARS-CoV-2 detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32558722|t=2020. Incidental Finding of COVID-19 Lung Infection in 18F-FDG PET/CT: What Should We Do?|pdf=|usr=010}}
| |
| − | {{tp|p=32578826|t=2020. Imaging findings in COVID-19 pneumonia.|pdf=|usr=010}}
| |
| − | {{tp|p=32576222|t=2020. VEGF-D: a novel biomarker for detection of COVID-19 progression.|pdf=|usr=010}}
| |
| − | {{tp|p=32560707|t=2020. Screening for low testosterone is needed for early identification and treatment of men at high risk of mortality from Covid-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32576508|t=2020. COVID-19 paraclinical diagnostic tools: Updates and future trends.|pdf=|usr=010}}
| |
| − | {{tp|p=32542842|t=2020. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis.|pdf=|usr=010}}
| |
| − | {{tp|p=32592840|t=2020. COVID 19 and low-glucose levels : is there a link ?|pdf=|usr=010}}
| |
| − | {{tp|p=32558646|t=2020. COVID-19 S: A new proposal for diagnosis and structured reporting of COVID-19 on computed tomography imaging.|pdf=|usr=010}}
| |
| − | {{tp|p=32558645|t=2020. CT imaging features of COVID-19 pneumonia: initial experience from Turkey.|pdf=|usr=010}}
| |
| − | {{tp|p=32557817|t=2020. B lines in COVID-19: "Unspecificity" is not "meaningless".|pdf=|usr=010}}
| |
| − | {{tp|p=32572392|t=2020. Eosinopenia as an early diagnostic marker of COVID-19 at the time of the epidemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32578687|t=2020. COVID-19 findings identified in chest computed tomography: a pictorial essay.|pdf=|usr=010}}
| |
| − | {{tp|p=32579876|t=2020. Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32543298|t=2020. Development of an automatic integrated gene detection system for novel Severe acute respiratory syndrome-related coronavirus (SARS-CoV 2).|pdf=|usr=010}}
| |
| − | {{tp|p=32572707|t=2020. The role of initial chest X-ray in triaging patients with suspected COVID-19 during the pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32586646|t=2020. Electrocardiographic features of patients with COVID-19 pneumonia.|pdf=|usr=010}}
| |
| − | {{tp|p=32562294|t=2020. Neurosonology during the COVID-19 pandemic (Editorial commentary from the chairs of the ultrasound panel of the EAN).|pdf=|usr=010}}
| |
| − | {{tp|p=32567006|t=2020. End-to-end automatic differentiation of the coronavirus disease 2019 (COVID-19) from viral pneumonia based on chest CT.|pdf=|usr=010}}
| |
| − | {{tp|p=32561970|t=2020. (18)F-Fluorocholine uptake matching CT lesions in the lungs of a patient clinically cured from COVID-19 syndrome.|pdf=|usr=010}}
| |
| − | {{tp|p=32556400|t=2020. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series.|pdf=|usr=010}}
| |
| − | {{tp|p=32591890|t=2020. Cohort study of chest CT and clinical changes in 29 patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=010}}
| |
| − | {{tp|p=32591888|t=2020. Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation.|pdf=|usr=010}}
| |
| − | {{tp|p=32592118|t=2020. Evaluation of novel coronavirus disease (COVID-19) using quantitative lung CT and clinical data: prediction of short-term outcome.|pdf=|usr=010}}
| |
| − | {{tp|p=32546849|t=2020. Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR.|pdf=|usr=010}}
| |
| − | {{tp|p=32570810|t=2020. Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler.|pdf=|usr=010}}
| |
| − | {{tp|p=32583171|t=2020. Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases.|pdf=|usr=010}}
| |
| − | {{tp|p=32553834|t=2020. Correlation between arterial blood gas test and CT volumetry in patients with SARS-CoV-2 in the emergency department.|pdf=|usr=010}}
| |
| − | {{tp|p=32575728|t=2020. Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs.|pdf=|usr=010}}
| |
| − | {{tp|p=32554983|t=2020. The Limited Sensitivity of Chest Computed Tomography Relative to Reverse Transcription Polymerase Chain Reaction for Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Systematic Review on COVID-19 Diagnostics.|pdf=|usr=010}}
| |
| − | {{tp|p=32542735|t=2020. An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32553841|t=2020. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32562192|t=2020. Multi-modality imaging of inflammation and ischemia for assessment of myocardial injury in Covid-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32568543|t=2020. Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32562109|t=2020. 2019 novel coronavirus (COVID-19) pneumonia complications: the importance of lung ultrasound.|pdf=|usr=010}}
| |
| − | {{tp|p=32554043|t=2020. Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections.|pdf=|usr=010}}
| |
| − | {{tp|p=32544099|t=2020. IL-6 combined with CD8+ T cell count early predict in-hospital mortality for patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32588277|t=2020. Chest computed tomography findings of COVID-19 pneumonia: pictorial essay with literature review.|pdf=|usr=010}}
| |
| − | {{tp|p=32577869|t=2020. (18)F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces.|pdf=|usr=010}}
| |
| − | {{tp|p=32542458|t=2020. Appropriate terms for chest CT features in COVID-19 infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32563278|t=2020. Association between high serum total cortisol concentrations and mortality from COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32590775|t=2020. Chest CT of COVID-19 in patients with a negative first RT-PCR test: Comparison with patients with a positive first RT-PCR test.|pdf=|usr=010}}
| |
| − | {{tp|p=32555547|t=2020. Severe COVID-19 in the young and healthy: monogenic inborn errors of immunity?|pdf=|usr=010}}
| |
| − | {{tp|p=32556807|t=2020. Coronavirus disease 2019 (COVID-19) in children: a systematic review of imaging findings.|pdf=|usr=010}}
| |
| − | {{tp|p=32588200|t=2020. Truncated inception net: COVID-19 outbreak screening using chest X-rays.|pdf=|usr=010}}
| |
| − | {{tp|p=32589673|t=2020. New machine learning method for image-based diagnosis of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32591286|t=2020. Reporting radiographers' interpretation and use of the British Society of Thoracic Imaging's coding system when reporting COVID-19 chest x-rays.|pdf=|usr=010}}
| |
| − | {{tp|p=32562280|t=2020. COVID-19 and ABO blood groups.|pdf=|usr=010}}
| |
| − | {{tp|p=32538694|t=2020. Coronavirus Disease (COVID-19) Detected at the Lung Apices During CT Angiography in Acute Stroke Assessment.|pdf=|usr=010}}
| |
| − | {{tp|p=32538693|t=2020. On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32583852|t=2020. Review of Current Advances in Serologic Testing for COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32577723|t=2020. Antibody Testing for COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32588812|t=2020. Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections.|pdf=|usr=010}}
| |
| − | {{tp|p=32573207|t=2020. Molecular diagnosis of COVID-19: Challenges and research needs.|pdf=|usr=010}}
| |
| − | {{tp|p=32568341|t=2020. Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus.|pdf=|usr=010}}
| |
| − | {{tp|p=32581086|t=2020. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32586931|t=2020. Testing strategy for SARS-CoV-2 in the paediatric emergency department.|pdf=|usr=010}}
| |
| − | {{tp|p=32586794|t=2020. Covid-19: Timing is critical for antibody tests, finds Cochrane review.|pdf=|usr=010}}
| |
| − | {{tp|p=32580937|t=2020. Covid-19 antibody tests: a briefing.|pdf=|usr=010}}
| |
| − | {{tp|p=32548635|t=2020. Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020.|pdf=|usr=010}}
| |
| − | {{tp|p=32544948|t=2020. Pool size selection when testing for SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32584464|t=2020. Antibody tests for identification of current and past infection with SARS-CoV-2.|pdf=|usr=010}}
| |
| − | {{tp|p=32568604|t=2020. A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32571201|t=2020. PET and SPECT Imaging in the SARS-CoV-2 Pandemic.|pdf=|usr=010}}
| |
| − | {{tp|p=32588938|t=2020. Serum Amyloid A protein has been undervalued as a biomarker in cases of COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32589600|t=2020. Biochemical biomarkers alterations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=010}}
| |
| − | {{tp|p=32576313|t=2020. A Proposed COVID-19 Testing Algorithm.|pdf=|usr=010}}
| |
| − | {{tp|p=32574401|t=2020. Usefulness of lung ultrasound imaging in COVID-19 pneumonia: The persisting need of safety and evidences.|pdf=|usr=010}}
| |
| − | {{tp|p=32556199|t=2020. Global evaluation of echocardiography in patients with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32584420|t=2020. LIPS method for the detection of SARS-CoV-2 antibodies to spike and nucleocapsid proteins.|pdf=|usr=010}}
| |
| − | {{tp|p=32588660|t=2020. The role of chest computed tomography in the management of COVID-19: A review of results and recommendations.|pdf=|usr=010}}
| |
| − | {{tp|p=32543300|t=2020. Laboratory abnormalities related to prolonged hospitalization in COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32569358|t=2020. COVID-19 TestNorm - A tool to normalize COVID-19 testing names to LOINC codes.|pdf=|usr=010}}
| |
| − | {{tp|p=32589736|t=2020. What to expect from antibody assays of SARS-CoV-2?|pdf=|usr=010}}
| |
| − | {{tp|p=32573713|t=2020. Laboratory tests and outcome for patients with COVID-19: A systematic review and meta-analysis.|pdf=|usr=010}}
| |
| − | {{tp|p=32571894|t=2020. Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection.|pdf=|usr=010}}
| |
| − | {{tp|p=32554480|t=2020. When to re-test: An examination of repeat COVID PCR patterns in an ambulatory population.|pdf=|usr=010}}
| |
| − | {{tp|p=32562797|t=2020. SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics.|pdf=|usr=010}}
| |
| − | {{tp|p=32558485|t=2020. Genomewide Association Study of Severe Covid-19 with Respiratory Failure.|pdf=|usr=010}}
| |
| − | {{tp|p=32569495|t=2020. Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32578403|t=2020. Rare CT manifestions of an asymptomatic girl with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32562732|t=2020. Computed Tomography, Deep Learning and Ultrasonography Role in the Diagnosis of COVID-19 Pendemic Lung Infection.|pdf=|usr=010}}
| |
| − | {{tp|p=32584166|t=2020. Spectrum of Imaging Findings on Chest Radiographs, US, CT, and MRI Images in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19.|pdf=|usr=010}}
| |
| − | {{tp|p=32570265|t=2020. Lung Ultrasound in COVID-19 Pneumonia: Correlations with Chest CT on Hospital admission.|pdf=|usr=010}}
| |
| − | {{tp|p=32554992|t=2020. Neutrophil-to-Lymphocyte Ratio and Outcomes in Louisiana Covid-19 Patients.|pdf=|usr=010}}
| |
| − | {{tp|p=32578378|t=2020. Nanopore Targeted Sequencing for the Accurate and Comprehensive Detection of SARS-CoV-2 and Other Respiratory Viruses.|pdf=|usr=010}}
| |
| − | {{tp|p=32584766|t=2020. [Radiological manifestation of COVID-19].|pdf=|usr=010}}
| |
| − | {{tp|p=32588412|t=2020. Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".|pdf=|usr=010}}
| |
| − | {{tp|p=32588411|t=2020. Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".|pdf=|usr=010}}
| |
| − | {{tp|p=32539257|t=2020. [Recommendations for treatment of severe coronavirus disease 2019 based on critical care ultrasound].|pdf=|usr=010}}
| |
| − |
| |
| − | {{tp|p=32537561|t=2020. Current and emerging diagnostic tests available for the novel COVID-19 global pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32546341|t=2020. COVID-19: The Importance of Multidisciplinary Approach.|pdf=|usr=011}}
| |
| − | {{tp|p=32542208|t=2020. Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay.|pdf=|usr=011}}
| |
| − | {{tp|p=32537173|t=2020. Simulated net-benefit of polymerase chain reaction test for COVID-19 among asymptomatic patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32247317|t=2020. Early Lessons on the Importance of Lung Imaging in Novel Coronavirus Disease (COVID-19).|pdf=|usr=011}}
| |
| − | {{tp|p=32238224|t=2020. The Importance of Diagnostic Testing during a Viral Pandemic: Early Lessons from Novel Coronavirus Disease (COVID-19).|pdf=|usr=011}}
| |
| − | {{tp|p=32422057|t=2020. Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.|pdf=|usr=011}}
| |
| − | {{tp|p=32539306|t=2020. Quality of Ribonucleic Acid Extraction for Real-Time Reverse Transcription-PCR (rRT-PCR) of SARS-CoV-2: Importance of Internal Control Monitoring.|pdf=|usr=011}}
| |
| − | {{tp|p=32539299|t=2020. COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays.|pdf=|usr=011}}
| |
| − | {{tp|p=32566623|t=2020. The positive of stool test for SARS-CoV-2: a report of 9 cases in Changsha, outside Wuhan, China.|pdf=|usr=011}}
| |
| − | {{tp|p=32566621|t=2020. Quantitative analysis of chest CT imaging findings with the risk of ARDS in COVID-19 patients: a preliminary study.|pdf=|usr=011}}
| |
| − | {{tp|p=32566620|t=2020. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters.|pdf=|usr=011}}
| |
| − | {{tp|p=32566572|t=2020. Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study.|pdf=|usr=011}}
| |
| − | {{tp|p=32566559|t=2020. Chest computed tomography for the diagnosis of patients with coronavirus disease 2019 (COVID-19): a rapid review and meta-analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32571605|t=2020. Laboratory Findings of COVID-19 Infection are Conflicting in Different Age Groups and Pregnant Women: A Literature Review.|pdf=|usr=011}}
| |
| − | {{tp|p=32596354|t=2020. Chest Computed Tomography Findings in COVID-19 and Influenza: A Narrative Review.|pdf=|usr=011}}
| |
| − | {{tp|p=32553350|t=2020. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis.|pdf=|usr=011}}
| |
| − | {{tp|p=32542672|t=2020. Rapid screening of COVID-19 patients by White blood cells scattergrams, a study on 381 patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32589534|t=2020. Radiological manifestations of COVID-19: key points for the physician.|pdf=|usr=011}}
| |
| − | {{tp|p=32558808|t=2020. Canadian Public Health Laboratory Network Statement on Point-of-Care Serology Testing in COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32595812|t=2020. Echocardiographic Characteristics of Subjects With COVID-19: A Case Series.|pdf=|usr=011}}
| |
| − | {{tp|p=32536759|t=2020. Application of deep learning for fast detection of COVID-19 in X-Rays using nCOVnet.|pdf=|usr=011}}
| |
| − | {{tp|p=32598879|t=2020. Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys(R) Anti-SARS-CoV-2 assay.|pdf=|usr=011}}
| |
| − | {{tp|p=32603801|t=2020. Validation of a commercially available SARS-CoV-2 serological immunoassay.|pdf=|usr=011}}
| |
| − | {{tp|p=32593741|t=2020. Diagnostic strategies for SARS-CoV-2 infection and interpretation of microbiological results.|pdf=|usr=011}}
| |
| − | {{tp|p=32199619|t=2020. The characteristics and clinical value of chest CT images of novel coronavirus pneumonia.|pdf=|usr=011}}
| |
| − | {{tp|p=32546365|t=2020. Diagnostic utility of additional whole-chest CT as part of an acute abdominal pain CT imaging pathway during the COVID-19 pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32600651|t=2020. A national UK audit for diagnostic accuracy of preoperative CT chest in emergency and elective surgery during COVID-19 pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32593409|t=2020. Chest CT screening for COVID-19 in elective and emergency surgical patients: experience from a UK tertiary centre.|pdf=|usr=011}}
| |
| − | {{tp|p=32550070|t=2020. Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass Opacities.|pdf=|usr=011}}
| |
| − | {{tp|p=32550054|t=2020. Effectiveness of Computed Tomography in the Diagnosis of Novel Coronavirus-2019.|pdf=|usr=011}}
| |
| − | {{tp|p=32571748|t=2020. Chest CT in COVID-19 pneumonia: A review of current knowledge.|pdf=|usr=011}}
| |
| − | {{tp|p=32571747|t=2020. Incidental diagnosis of Covid-19 pneumonia on chest computed tomography.|pdf=|usr=011}}
| |
| − | {{tp|p=32593875|t=2020. Heat inactivation decreases the qualitative real-time RT-PCR detection rates of clinical samples with high cycle threshold values in COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32604919|t=2020. Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics.|pdf=|usr=011}}
| |
| − | {{tp|p=32545412|t=2020. COVID-19 Infection Diagnosis: Potential Impact of Isothermal Amplification Technology to Reduce Community Transmission of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32545224|t=2020. Group Testing-Based Robust Algorithm for Diagnosis of COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32603290|t=2020. Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents.|pdf=|usr=011}}
| |
| − | {{tp|p=32552549|t=2020. Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing.|pdf=|usr=011}}
| |
| − | {{tp|p=32594211|t=2020. Comparison of the computed tomography findings in COVID-19 and other viral pneumonia in immunocompetent adults: a systematic review and meta-analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32607634|t=2020. A predictive model and scoring system combining clinical and CT characteristics for the diagnosis of COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32610080|t=2020. The COVID-19 Serology Studies Workshop: Recommendations and Challenges.|pdf=|usr=011}}
| |
| − | {{tp|p=32599282|t=2020. Efficacy of a novel SARS-CoV-2 detection kit without RNA extraction and purification.|pdf=|usr=011}}
| |
| − | {{tp|p=32595004|t=2020. Echocardiographic Findings in Patients with COVID-19 with Significant Myocardial Injury.|pdf=|usr=011}}
| |
| − | {{tp|p=32603773|t=2020. Utility of nasopharyngeal swabs in series before hospitalization during SARS-CoV-2 outbreak.|pdf=|usr=011}}
| |
| − | {{tp|p=32603675|t=2020. Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.|pdf=|usr=011}}
| |
| − | {{tp|p=32607737|t=2020. Detection of COVID-19 Infection from Routine Blood Exams with Machine Learning: A Feasibility Study.|pdf=|usr=011}}
| |
| − | {{tp|p=32601795|t=2020. Sars-Cov-2 interference in HEME production: is it the time for an early predictive biomarker?|pdf=|usr=011}}
| |
| − | {{tp|p=32593686|t=2020. Dog Bites in Children Surge during COVID-19: A Case for Enhanced Prevention.|pdf=|usr=011}}
| |
| − | {{tp|p=32600984|t=2020. Lung ultrasound in the frontline diagnosis of COVID-19 infection.|pdf=|usr=011}}
| |
| − | {{tp|p=32593746|t=2020. Interleukin-6 and Severity of COVID-19 Patients in Hefei, China.|pdf=|usr=011}}
| |
| − | {{tp|p=32607246|t=2020. Laboratory diagnosis of SARS-CoV-2: available approaches and limitations.|pdf=|usr=011}}
| |
| − | {{tp|p=32605363|t=2020. A SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Towards the Development of Point of Care Tests Using Commercially Available Reagents.|pdf=|usr=011}}
| |
| − | {{tp|p=32540814|t=2020. Groupe de travail SFBC << Marqueurs biochimiques de COVID-19 >>.|pdf=|usr=011}}
| |
| − | {{tp|p=32581016|t=2020. Clinical Characteristics and Blood Test Results in COVID-19 Patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32609874|t=2020. ABO Phenotype and Death in Critically Ill Patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32589547|t=2020. Different manifestations of COVID-19 pneumonia in a child: focal crazy paving sign on chest and three-dimensional computed tomography.|pdf=|usr=011}}
| |
| − | {{tp|p=32584604|t=2020. Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32539541|t=2020. Cardiac Troponin I is an Independent Predictor for Mortality in Hospitalized Patients with Coronavirus Disease 2019.|pdf=|usr=011}}
| |
| − | {{tp|p=32598305|t=2020. Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?|pdf=|usr=011}}
| |
| − | {{tp|p=32598303|t=2020. Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32598302|t=2020. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing.|pdf=|usr=011}}
| |
| − | {{tp|p=32573995|t=2020. Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.|pdf=|usr=011}}
| |
| − | {{tp|p=32573469|t=2020. SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics.|pdf=|usr=011}}
| |
| − | {{tp|p=32554832|t=2020. Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32549133|t=2020. Variability between testing methods for SARS-CoV-2 nucleic acid detection 16 days post-discharge: a case report.|pdf=|usr=011}}
| |
| − | {{tp|p=32609644|t=2020. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.|pdf=|usr=011}}
| |
| − | {{tp|p=32609640|t=2020. Development and multicenter performance evaluation of fully automated SARS-CoV-2 IgM and IgG immunoassays.|pdf=|usr=011}}
| |
| − | {{tp|p=32562665|t=2020. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32538830|t=2020. Contrast enhanced ultrasound (CEUS) to assess pleural pulmonal changes in severe Covid 19 infection: First results.|pdf=|usr=011}}
| |
| − | {{tp|p=32596725|t=2020. Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32584972|t=2020. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=011}}
| |
| − | {{tp|p=32562544|t=2020. Posterior oropharyngeal saliva for the detection of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32538056|t=2020. Laboratory Findings in SARS-CoV-2 Infections in Zigong, China: Key Points for Serum Prealbumin.|pdf=|usr=011}}
| |
| − | {{tp|p=32599338|t=2020. Explainable Deep Learning for Pulmonary Disease and Coronavirus COVID-19 Detection from X-rays.|pdf=|usr=011}}
| |
| − | {{tp|p=32585083|t=2020. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.|pdf=|usr=011}}
| |
| − | {{tp|p=32600484|t=2020. Laboratory findings and a combined multifactorial approach to predict death in critically ill patients with COVID-19: a retrospective study.|pdf=|usr=011}}
| |
| − | {{tp|p=32602604|t=2020. Clinical Features of COVID-19-Infected Patients With Elevated Liver Biochemistries: A Multicenter, Retrospective Study.|pdf=|usr=011}}
| |
| − | {{tp|p=32587218|t=2020. New challenges and workaround: Ultrasound biomicroscopy in time of COVID-19 pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32603629|t=2020. Serological characteristics of COVID-19 patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32602679|t=2020. Clinico-Radiological Evaluation and Correlation of CT Chest Images with Progress of Disease in COVID-19 Patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32602678|t=2020. Clinico-radiological Presentation of COVID-19 Patients at a Tertiary Care Center at Bhilwara Rajasthan, India.|pdf=|usr=011}}
| |
| − | {{tp|p=32602674|t=2020. Laboratory Diagnosis of COVID 19 - Perspectives.|pdf=|usr=011}}
| |
| − | {{tp|p=32609429|t=2020. Raman Spectroscopy Based Detection of RNA viruses in Saliva: a preliminary report.|pdf=|usr=011}}
| |
| − | {{tp|p=32599571|t=2020. The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?|pdf=|usr=011}}
| |
| − | {{tp|p=32531777|t=2020. Breath analysis for detection of viral infection, the current position of the field.|pdf=|usr=011}}
| |
| − | {{tp|p=32594577|t=2020. Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32518071|t=2020. Evaluation of COVID-19 IgG/IgM Rapid Test from Orient Gene Biotech.|pdf=|usr=011}}
| |
| − | {{tp|p=32513859|t=2020. Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32513858|t=2020. Clinical Performance of SARS-CoV-2 Molecular Testing.|pdf=|usr=011}}
| |
| − | {{tp|p=32540034|t=2020. A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32541273|t=2020. Saliva as a Potential Diagnostic Specimen for COVID-19 Testing.|pdf=|usr=011}}
| |
| − | {{tp|p=32594170|t=2020. Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.|pdf=|usr=011}}
| |
| − | {{tp|p=32592581|t=2020. Group Testing for Sars-Cov-2 to Enable Rapid Scale-Up of Testing and Real-Time Surveillance of Incidence.|pdf=|usr=011}}
| |
| − | {{tp|p=32582936|t=2020. Elevated Serum Endothelial Cell Adhesion Molecules Expression in COVID-19 Patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32608016|t=2020. Is susceptibility to severe COVID-19 disease an inborn error of metabolism?|pdf=|usr=011}}
| |
| − | {{tp|p=32603484|t=2020. Matrix Metalloproteinase 3 as a Valuable Marker for Patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32592502|t=2020. Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019.|pdf=|usr=011}}
| |
| − | {{tp|p=32592498|t=2020. Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?|pdf=|usr=011}}
| |
| − | {{tp|p=32579256|t=2020. Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?|pdf=|usr=011}}
| |
| − | {{tp|p=32579236|t=2020. Meta-analysis of chest CT features of patients with COVID-19 pneumonia.|pdf=|usr=011}}
| |
| − | {{tp|p=32568413|t=2020. Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for Covid-19: A meta-analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32589348|t=2020. COVID-19 Screening with Chest CT in Acute Stroke Imaging: A Clinical Decision Model.|pdf=|usr=011}}
| |
| − | {{tp|p=32594977|t=2020. Psychological states of COVID-19 quarantine.|pdf=|usr=011}}
| |
| − | {{tp|p=32604085|t=2020. Dose optimized chest CT for diagnosis of COVID-19 - Evaluation of the image quality and diagnostic impact.|pdf=|usr=011}}
| |
| − | {{tp|p=32558725|t=2020. Detection of Unsuspected Coronavirus Disease 2019 Cases by Computed Tomography and Retrospective Implementation of the Radiological Society of North America/Society of Thoracic Radiology/American College of Radiology Consensus Guidelines.|pdf=|usr=011}}
| |
| − | {{tp|p=32555006|t=2020. A Novel Machine Learning-derived Radiomic Signature of the Whole Lung Differentiates Stable From Progressive COVID-19 Infection: A Retrospective Cohort Study.|pdf=|usr=011}}
| |
| − | {{tp|p=32609971|t=2020. Lung ultrasound in a Singapore COVID-19 intensive care unit patient and a review of its potential clinical utility in pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32568167|t=2020. Differentiating pneumonia with and without COVID-19 using chest CT images: from qualitative to quantitative.|pdf=|usr=011}}
| |
| − | {{tp|p=32538893|t=2020. Clinical and radiological features of novel coronavirus pneumonia.|pdf=|usr=011}}
| |
| − | {{tp|p=32514951|t=2020. COVID-19-Antikorper-Bluttest erhalt CE-Zeichen.|pdf=|usr=011}}
| |
| − | {{tp|p=32203294|t=2020. Fast, portable tests come online to curb coronavirus pandemic.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32473864|t=2020. Keys for analysis of diagnostic and serologic tests for CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32550256|t=2020. Review of chest CT manifestations of COVID-19 infection.|pdf=|usr=011}}
| |
| − | {{tp|p=32444412|t=2020. A Fully Automatic Deep Learning System for COVID-19 Diagnostic and Prognostic Analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32583765|t=2020. Multicentre comparison of quantitative PCR-based assays to detect SARS-CoV-2, Germany, March 2020.|pdf=|usr=011}}
| |
| − | {{tp|p=32553061|t=2020. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications.|pdf=|usr=011}}
| |
| − | {{tp|p=32591666|t=2020. Saliva: a diagnostic option and a transmission route for 2019-nCoV.|pdf=|usr=011}}
| |
| − | {{tp|p=32582718|t=2020. Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2).|pdf=|usr=011}}
| |
| − | {{tp|p=32574316|t=2020. Development of Point-of-Care Biosensors for COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32582302|t=2020. Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes.|pdf=|usr=011}}
| |
| − | {{tp|p=32582748|t=2020. Early Detection and Assessment of Covid-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32574326|t=2020. Development and Potential Usefulness of the COVID-19 Ag Respi-Strip Diagnostic Assay in a Pandemic Context.|pdf=|usr=011}}
| |
| − | {{tp|p=32574321|t=2020. Clinical Time Features and Chest Imaging of 85 Patients With COVID-19 in Zhuhai, China.|pdf=|usr=011}}
| |
| − | {{tp|p=32544396|t=2020. Mild Pancreatic Enzyme Elevations in COVID-19 Pneumonia: Synonymous with Injury or Noise?|pdf=|usr=011}}
| |
| − | {{tp|p=32544393|t=2020. SARS-CoV-2 RNA Detection in Gastrointestinal Sample Displays Poor Performance.|pdf=|usr=011}}
| |
| − | {{tp|p=32424671|t=2020. The Role of Non-Contrast Chest CT in Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) Pediatric Patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32397262|t=2020. Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?|pdf=|usr=011}}
| |
| − | {{tp|p=32547309|t=2020. Characteristics of in peripheral blood of 70 hospitalized patients and 8 diarrhea patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32424603|t=2020. COVID-19 in adults: test menu for hospital blood science laboratories.|pdf=|usr=011}}
| |
| − | {{tp|p=32590015|t=2020. Radiologist Reporting and Operational Management for Patients With Suspected COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32580898|t=2020. Echocardiographic Features of COVID-19 Illness and Association with Cardiac Biomarkers.|pdf=|usr=011}}
| |
| − | {{tp|p=32561110|t=2020. Transesophageal Echocardiography Remains Essential and Safe during Prone Ventilation for Hemodynamic Monitoring of Patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32561109|t=2020. Tricuspid Longitudinal Annular Displacement for the Assessment of Right Ventricular Systolic Dysfunction during Prone Positioning in Patients with COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32544622|t=2020. Electrocardiographic Findings in Coronavirus Disease-19: Insights on Mortality and Underlying Myocardial Processes.|pdf=|usr=011}}
| |
| − | {{tp|p=32547838|t=2020. The Role of Chest Computed Tomography in Asymptomatic Patients of Positive Coronavirus Disease 2019: A Case and Literature Review.|pdf=|usr=011}}
| |
| − | {{tp|p=32560044|t=2020. Performance Assessment of SARS-CoV-2 PCR Assays Developed by WHO Referral Laboratories.|pdf=|usr=011}}
| |
| − | {{tp|p=32580948|t=2020. Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In COVID-19 Patients Semiquantitatively.|pdf=|usr=011}}
| |
| − | {{tp|p=32578070|t=2020. COVID-19: Pulse oximeters in the spotlight.|pdf=|usr=011}}
| |
| − | {{tp|p=32585619|t=2020. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus.|pdf=|usr=011}}
| |
| − | {{tp|p=32570045|t=2020. Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32593133|t=2020. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).|pdf=|usr=011}}
| |
| − | {{tp|p=32563180|t=2020. Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation.|pdf=|usr=011}}
| |
| − | {{tp|p=32544861|t=2020. A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results.|pdf=|usr=011}}
| |
| − | {{tp|p=32556893|t=2020. Home testing for COVID-19: lessons from direct to consumer genetics.|pdf=|usr=011}}
| |
| − | {{tp|p=32495086|t=2020. Interpreting COVID-19 Test Results: a Bayesian Approach.|pdf=|usr=011}}
| |
| − | {{tp|p=32592705|t=2020. Serum ferritin as an independent risk factor for severity in COVID-19 patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32579988|t=2020. RAPID SALIVARY TEST SUITABLE FOR A MASS SCREENING PROGRAM TO DETECT SARS-COV-2: A DIAGNOSTIC ACCURACY STUDY.|pdf=|usr=011}}
| |
| − | {{tp|p=32579986|t=2020. Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus.|pdf=|usr=011}}
| |
| − | {{tp|p=32579983|t=2020. Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32569603|t=2020. Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration.|pdf=|usr=011}}
| |
| − | {{tp|p=32562790|t=2020. Should qualitative RT-PCR be used to determine release from isolation of COVID-19 patients?|pdf=|usr=011}}
| |
| − | {{tp|p=32540459|t=2020. Prognostic value of carcinoembryonic antigen on outcome in patients with coronavirus disease 2019.|pdf=|usr=011}}
| |
| − | {{tp|p=32568730|t=2020. COVID-19 Pneumonia Diagnosis Using a Simple 2D Deep Learning Framework With a Single Chest CT Image: Model Development and Validation.|pdf=|usr=011}}
| |
| − | {{tp|p=32543753|t=2020. Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32581183|t=2020. Saliva-based PCR tests for SARS-CoV-2 detection.|pdf=|usr=011}}
| |
| − | {{tp|p=32573706|t=2020. Simulation of Pool Testing to Identify Patients With Coronavirus Disease 2019 Under Conditions of Limited Test Availability.|pdf=|usr=011}}
| |
| − | {{tp|p=32530469|t=2020. Assessment of Sensitivity and Specificity of Patient-Collected Lower Nasal Specimens for Sudden Acute Respiratory Syndrome Coronavirus 2 Testing.|pdf=|usr=011}}
| |
| − | {{tp|p=32586670|t=2020. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis.|pdf=|usr=011}}
| |
| − | {{tp|p=32558308|t=2020. Genetic variability of human angiotensin-converting enzyme 2 (hACE2) among various ethnic populations.|pdf=|usr=011}}
| |
| − | {{tp|p=32577428|t=2020. Early-Morning vs Spot Posterior Oropharyngeal Saliva for Diagnosis of SARS-CoV-2 Infection: Implication of Timing of Specimen Collection for Community-Wide Screening.|pdf=|usr=011}}
| |
| − | {{tp|p=32471801|t=2020. Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.|pdf=|usr=011}}
| |
| − | {{tp|p=32582332|t=2020. Rational and practical use of imaging in COVID-19 pneumonia.|pdf=|usr=011}}
| |
| − | {{tp|p=32582309|t=2020. Chest X-rays findings in COVID 19 patients at a University Teaching Hospital - A descriptive study.|pdf=|usr=011}}
| |
| − | {{tp|p=32596046|t=2020. Novel rapid identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by real-time RT-PCR using BD Max Open System in Taiwan.|pdf=|usr=011}}
| |
| − | {{tp|p=32547882|t=2020. Real-time reverse transcription loop-mediated isothermal amplification for rapid detection of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32590234|t=2020. Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers.|pdf=|usr=011}}
| |
| − | {{tp|p=32550141|t=2020. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32550140|t=2020. Chest CT study of fifteen COVID-19 patients with positive RT-PCR retest results after discharge.|pdf=|usr=011}}
| |
| − | {{tp|p=32550139|t=2020. Chest lesion CT radiological features and quantitative analysis in RT-PCR turned negative and clinical symptoms resolved COVID-19 patients.|pdf=|usr=011}}
| |
| − | {{tp|p=32542102|t=2020. Incidental typical COVID-19 appearance on the lung bases, visualized at abdominal CT for a patient that presented with abdominal pain and nausea.|pdf=|usr=011}}
| |
| − | {{tp|p=32550601|t=2020. COVID-19 Update from the NCI Cancer Imaging Program.|pdf=|usr=011}}
| |
| − | {{tp|p=32049600|t=2020. Use of Chest CT in Combination with Negative RT-PCR Assay for the 2019 Novel Coronavirus but High Clinical Suspicion.|pdf=|usr=011}}
| |
| − | {{tp|p=32566476|t=2020. Detection of SARS-CoV-2 by bronchoscopy after negative nasopharyngeal testing: Stay vigilant for COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32609256|t=2020. SARS-CoV-2 and the COVID-19 disease: a mini review on diagnostic methods.|pdf=|usr=011}}
| |
| − | {{tp|p=32547616|t=2020. Ferritin levels and COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32592085|t=2020. Could urinary ACE2 protein level help identify individuals susceptible to SARS-CoV-2 infection and complication?|pdf=|usr=011}}
| |
| − | {{tp|p=32567003|t=2020. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases.|pdf=|usr=011}}
| |
| − | {{tp|p=32581324|t=2020. Temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearance.|pdf=|usr=011}}
| |
| − | {{tp|p=32580213|t=2020. COVID-19 and the role of imaging: early experiences in Central Switzerland.|pdf=|usr=011}}
| |
| − | {{tp|p=32599095|t=2020. The Acute Respiratory Distress Syndrome Biomarker Pipeline: Crippling Gaps between Discovery and Clinical Utility.|pdf=|usr=011}}
| |
| − | {{tp|p=32567505|t=2020. Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer.|pdf=|usr=011}}
| |
| − | {{tp|p=32591166|t=2020. A Review of Early Experience in Lung Ultrasound in the Diagnosis and Management of COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32593499|t=2020. Rationale for the Routine Application of Lung Ultrasound in the Management of Coronavirus Disease 2019 (COVID-19) Patients in Middle- to Low-Income Countries.|pdf=|usr=011}}
| |
| − | {{tp|p=32605577|t=2020. Evaluation of SARS-CoV-2 viral RNA in fecal samples.|pdf=|usr=011}}
| |
| − | {{tp|p=32558519|t=2020. Neumonia por COVID-19: hallazgos tomograficos.|pdf=|usr=011}}
| |
| − | {{tp|p=32584323|t=2020. MEXICAN HUMAN LEUKOCYTE ANTIGEN ALLELES MIGHT PREDICT CLINICAL OUTCOME IN SARS-COV-2 INFECTED PATIENTS.|pdf=|usr=011}}
| |
| − | {{tp|p=32543154|t=2020. [Dynamic Changes of CT Findings in Pneumonia Patients with Coronavirus Disease 19].|pdf=|usr=011}}
| |
| − | {{tp|p=32604588|t=2020. Setting up an Easy-to-Use Machine Learning Pipeline for Medical Decision Support: A Case Study for COVID-19 Diagnosis Based on Deep Learning with CT Scans.|pdf=|usr=011}}
| |
| − | {{tp|p=32576346|t=2020. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].|pdf=|usr=011}}
| |
| − | {{tp|p=32576345|t=2020. [Clinical characteristics and CT imaging features of patients with different clinical types of coronavirus disease 2019].|pdf=|usr=011}}
| |
| − | {{tp|p=32157849|t=2020. [Construction and evaluation of a novel diagnosis pathway for 2019-Corona Virus Disease].|pdf=|usr=011}}
| |
